SYDNEY, Nov. 18, 2019 /PRNewswire/ -- The iQ Group Global, an enterprise dedicated to developing early stage bioscience assets, announced that Dr. Jonathan Arambula will join The iQ Group Global as ...
SYDNEY, Jan. 31, 2019 /PRNewswire/ -- The iQ Group Global, a consortium of life science and financial services companies which span the biopharma value chain from asset discovery to commercialization, ...
SYDNEY, Oct. 19, 2021 /PRNewswire/ -- The iQ Group Global Ltd (NSX.IQG), on behalf of its subsidiary, Life Science Biosensor Diagnostics Pty Ltd (LSBD), is pleased to announce that one of its ...
Harvard University’s Wyss Institute for Biologically Inspired Engineering licensed its Erapid electrochemical sensing platform to IQ Group Global to integrate with the Australian consortium’s ...
(BOSTON) -- Today, the Wyss Institute for Biologically Inspired Engineering at Harvard University announced that its eRapid technology has been licensed to The iQ Group Global for COVID-19 diagnostic ...
The Wyss Institute for Biologically Inspired Engineering at Harvard University and GBS Inc., a subsidiary of The iQ Group Global, announce that they will collaborate to validate and de-risk a specific ...
An Australia-based biotechnology company has acquired an anti-cancer drug platform developed by University of Texas researchers, the company said Monday. IQ Global, which specializes in finding and ...
Combination of the Wyss' electrochemical sensing technology with GBS's transistor technology could enable fast, multiplexed, low-cost COVID-19 biomarker analysis in point-of-care applications. (BOSTON ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback